Literature DB >> 8104011

Effect of aggressive haemoperfusion on the clinical course of patients with paraquat poisoning.

K Suzuki1, N Takasu, T Okabe, S Ishimatsu, A Ueda, S Tanaka, A Fukuda, S Arita, A Kohama.   

Abstract

The effect of aggressive haemoperfusion; i.e. haemoperfusion of 10 h or more during the first 24 h after ingestion, on the clinical course of paraquat poisoning was studied. Among 40 patients admitted within 15 h after ingestion of paraquat with an SIPP of less than 100 (h x micrograms ml-1), 21 received aggressive haemoperfusion and 19 received conventional haemoperfusion; i.e. haemoperfusion of less than 10 h during the same period. Survival rates of patients with severity between an SIPP of 100 and Proudfoot's curve in the two groups were compared by the log-rank test. Aggressive haemoperfusion did not improve the outcome but did improve the survival rates; that is, the number of patients surviving at particular points in time (P < 0.05). The length of haemoperfusion for the aggressive haemoperfusion group was longer than that for the conventional group on the first day (P < 0.001), but the difference was insignificant during the following two days. Neither the time from ingestion to haemoperfusion, urine volume from the first to third day, nor initial plasma-paraquat concentrations and SIPP were significant between groups. These findings imply that aggressive haemoperfusion reduces the severity of paraquat poisoning and elongates survival time. We, therefore, propose that the efficacy of more aggressive haemoperfusion, such as the 'continuous haemoperfusion' proposed by Okonek et al., should be further studied.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8104011     DOI: 10.1177/096032719301200411

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  8 in total

1.  Cyclophosphamide treatment of paraquat poisoning.

Authors:  C G Newstead
Journal:  Thorax       Date:  1996-07       Impact factor: 9.139

Review 2.  Prospects for treatment of paraquat-induced lung fibrosis with immunosuppressive drugs and the need for better prediction of outcome: a systematic review.

Authors:  M Eddleston; M F Wilks; N A Buckley
Journal:  QJM       Date:  2003-11

3.  Early hemoperfusion may improve survival of severely paraquat-poisoned patients.

Authors:  Ching-Wei Hsu; Ja-Liang Lin; Dan-Tzu Lin-Tan; Kuan-Hsing Chen; Tzung-Hai Yen; Mai-Szu Wu; Shih-Chieh Lin
Journal:  PLoS One       Date:  2012-10-29       Impact factor: 3.240

4.  Is endotracheal intubation a non-beneficial treatment in patients with respiratory failure due to paraquat poisoning?

Authors:  Meng-Ruey Wu; Chia-Ying Hsiao; Chun-Han Cheng; Feng-Ching Liao; Chuan-Lei Chao; Chun-Yen Chen; Hung-I Yeh; Min-I Su
Journal:  PLoS One       Date:  2018-03-28       Impact factor: 3.240

5.  The value of plasma paraquat concentration in predicting therapeutic effects of haemoperfusion in patients with acute paraquat poisoning.

Authors:  Yunying Shi; Yangjuan Bai; Yuangao Zou; Bei Cai; Fei Liu; Ping Fu; Lanlan Wang
Journal:  PLoS One       Date:  2012-07-20       Impact factor: 3.240

6.  Addition of immunosuppressive treatment to hemoperfusion is associated with improved survival after paraquat poisoning: a nationwide study.

Authors:  Wen-Pyng Wu; Ming-Nan Lai; Ching-Heng Lin; Yu-Fen Li; Ching-Yuang Lin; Ming-Ju Wu
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

7.  Therapeutic effects of smecta or smectite powder on rats with paraquat toxication.

Authors:  Yin-Song Jiang; Yu-Ying Ma; Zhan-Qing Wang; Guang-Jun Li
Journal:  World J Emerg Med       Date:  2013

8.  Toxicokinetics of paraquat in Korean patients with acute poisoning.

Authors:  Hak-Jae Kim; Hyung-Ki Kim; Hwayoung Lee; Jun-Seok Bae; Jun-Tack Kown; Hyo-Wook Gil; Sae-Yong Hong
Journal:  Korean J Physiol Pharmacol       Date:  2015-12-31       Impact factor: 2.016

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.